Answer: is <em>c. </em><em><u>The patient may have no more than 5 refills in a 6-month period</u></em>.
Explanation: Schedule C-III medications will not be refilled more than five times in 6 months period of time. Schedule 3 catogory of drugs may contain, valium, tranquillisers, anabolic steroids, testosterone, Tylenol, codeine and Ketamine. The reason behind why patient should not have more refills in a 6 month period of time is because by consuming these drugs patient may experience mild physical dependence or very high physiological dependence. Patient may experience addition (mild to high) while taking schedule C-III drugs. Although schedule C-III drugs are less abusive then schedule 1 and schedule 2 drugs. Schedule 3 drugs are declared as sightly dangerous.
Answer:
The counter-current multiplier or the countercurrent mechanism is used to concentrate urine in the kidneys by the nephrons of the human excretory system. The nephrons involved in the formation of concentrated urine extend all the way from the cortex of the kidney to the medulla and are accompanied by vasa recta.
Answer:
D. I, IV, VI, and VII
Explanation:
DNA polymerase III has both 5' to 3' polymerization activity and 3' to 5' exonuclease activity (the proofreading). DNA pol III requires divalent magnesium ions for its polymerization and proofreading activities. Here, the magnesium ions serve as cofactor.
DNA polymerase III cannot start the process of synthesis of new DNA strand de novo and uses an RNA primer synthesized by primase enzyme. The polymerization activity of DNA polymerase III elongates the RNA primer in 5' to 3' direction. The primers are removed by 5' to 3' exonuclease activity of DNA polymerase I.
During polymerization, the DNA polymerase III uses existing DNA strand as a template. The four dNTPs namely deoxyadenosine triphosphate (dATP), deoxycytidine triphosphate (dCTP), deoxyguanosine triphosphate (dGTP) and deoxythymidine triphosphate (dTTP) are added to the RNA primer according to the sequence of DNA template.
Why did he??????
................................
